Validation of serum transthyretin (prealbumin) as a nutritional parameter in hemodialysis patients
- PMID: 9724504
- DOI: 10.1016/s1051-2276(98)90006-1
Validation of serum transthyretin (prealbumin) as a nutritional parameter in hemodialysis patients
Abstract
Objective: To evaluate the use of serum transthyretin (TTR) as a valid indicator of nutritional status in the hemodialysis patient and to validate the correlation of low-serum (TTR) levels with established nutrition assessment parameters.
Design: Prospective, cohort, correlation analysis.
Setting: Free-standing outpatient dialysis center.
Patients: Fifty-one stable, chronic hemodialysis patients meeting the following selection criteria: (1) received thrice weekly hemodialysis treatments for greater than 3 months, (2) absence of impaired hepatic function, (3) absence of chronic infection, inflammatory syndromes, or infections in the 3 months before the study, (4) not taking corticosteroids, and (5) willing to participate in the study as evidenced by signing of an informed consent.
Intervention: Serum TTR, albumin, blood urea nitrogen, creatinine, cholesterol, postdialysis weight and body mass index were measured monthly for 6 consecutive months. Normalized protein catabolic rate and KT/V were measured monthly for 3 consecutive months.
Main outcome measures: Nutrition and biochemical indices.
Results: The overall mean TTR level was 32 mg/dL +/- 7 for the 6-month study period. Thirty-six percent of patients had mean TTR levels less than 30 mg/dL. TTR levels less than 30 mg/dL correlated significantly with urine outputs greater than 240 mL/24 hours, predialysis blood urea nitrogen < 18 mmol/L (<50 mg/dL), and normalized protein catabolic rate less than 0.8 g/kg/d (P < .05). A significant correlation was found between TTR and creatinine, albumin and loss of dry body weight (P < .05). Mean TTR levels less than 30 mg/dL were found in 33% of subjects with mean albumin levels greater than 35 g/L (>3.5 g/dL) and in 19% with mean albumin levels greater than 40 g/L (>4.0 g/dL). TTR levels were consistently lower in diabetics for all 6 months (statistically significant in 2 out of 6 months).
Conclusion: Measuring serial serum TTR levels in hemodialysis patients is a reliable method for identifying patients in need of nutrition intervention.
Similar articles
-
Dialyzer membrane permeability and survival in hemodialysis patients.Am J Kidney Dis. 2005 Mar;45(3):565-71. doi: 10.1053/j.ajkd.2004.11.014. Am J Kidney Dis. 2005. PMID: 15754279
-
Observations with regard to the National Kidney Foundation K/DOQI clinical practice guidelines concerning serum transthyretin in chronic renal failure.Clin Chem Lab Med. 2002 Dec;40(12):1308-12. doi: 10.1515/CCLM.2002.225. Clin Chem Lab Med. 2002. PMID: 12553435
-
Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients.Am J Kidney Dis. 2001 Jan;37(1 Suppl 2):S81-8. doi: 10.1053/ajkd.2001.20756. Am J Kidney Dis. 2001. PMID: 11158868
-
Metabolism and clinical interest of serum transthyretin (prealbumin) in dialysis patients.Clin Chem Lab Med. 2002 Dec;40(12):1313-9. doi: 10.1515/CCLM.2002.226. Clin Chem Lab Med. 2002. PMID: 12553436 Review.
-
Plasma Transthyretin as A Biomarker of Sarcopenia in Elderly Subjects.Nutrients. 2019 Apr 21;11(4):895. doi: 10.3390/nu11040895. Nutrients. 2019. PMID: 31010086 Free PMC article. Review.
Cited by
-
Transthyretin increases migration and invasion of rat placental trophoblast cells.FEBS Open Bio. 2020 Aug;10(8):1568-1576. doi: 10.1002/2211-5463.12911. Epub 2020 Jul 1. FEBS Open Bio. 2020. PMID: 32533762 Free PMC article.
-
Parenteral nutrition: Revisited.Indian J Anaesth. 2010 Mar;54(2):95-103. doi: 10.4103/0019-5049.63637. Indian J Anaesth. 2010. PMID: 20661345 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous